Home
About Us
Our Products
Our Science
Contact Us
News

PRODUCTSDon’t worry, we have it

Bring to the table win-win survival strategies to ensure proactive domination. At the end of the day, going forward.

bt_bb_section_bottom_section_coverage_image

Recent Posts

August 23, 2023Lepton Announced Completion of Filing for a Patent Application Extending the Usage of Its Castling Breakthrough Technologies
July 13, 2023Lepton Pharmaceuticals Completed the Extension Worldwide of its International Patent Covering the Breakthrough Castling Technology
March 20, 2023Lepton Pharmaceuticals enter into a Master Service Agreement with Reaction Biology to advance Lepton’s miRNA Castling Technology
July 26, 2022ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
February 14, 2022Lepton signs Consulting Agreement with Cell Therapy Expert Dr. Elena Sotillo, Senior Research Scientist at the lab of Prof. Crystal Mackall founding director, Center for Cancer Cell Therapy, Stanford Cancer Institute, Palo Alto, Ca, USA

https://www.leptonpharma.com/wp-content/uploads/2021/04/logo_white_big-160x160.png

© 2023 Lepton Pharmaceuticals Inc. All rights reserved
Design & Development by WCT

Our products

LN-Cast-01
LN-008 siMASP2

Our science

Castling Technology
siRNA and miRNA
Non-coding RNA
siRNA Advantages

Terms of use

Terms of Use
Copyright Info
Privacy Policy